Grants Available for Novel Approaches to Treating Alzheimer's Disease

A new grant to encourage novel approaches to therapy for Alzheimer's disease has been established by the University of Sydney's Sir Zelman Cowen Universities Fund (SZCUF).
The award of $250,000 over two years will fund a project aiming to develop and/or assess new treatments for the condition.
The Sir Zelman Cowen Universities Fund has supported research and scientific work at the University of Sydney and the Hebrew University of Jerusalem for over 35 years. This support has included a number of previous grant programs in the field of Alzheimer's disease research.
One of the Fund's Trustees, Professor David Celermajer AO FAA, understands from his own personal work as a physician-scientist that attracting the funds to get good projects off to a good start is often very difficult. Professor Celermajer said novel approaches are desperately required in the field of Alzheimer's disease research.
"Through its work supporting scientific projects over the years, the SZCUF has come to realise the significant role it can play in providing the funds required to get an important project off the ground, giving it early data needed to compete for later support from larger granting bodies.
"Moreover, the Fund's work has always also aimed to promote co-operative work between the University of Sydney and the Hebrew University of Jerusalem. "Given the levels of expertise in this field at both Universities, the Trustees feel a joint project between scientists of the two Universities may result in a finding that will make a real difference in this field. "Hence, while the grant is open to individual applicants from both the University of Sydney and the Hebrew University of Jerusalem, applications for joint projects from scientists of the two Universities are encouraged and will be given preference."
Application forms and more information about the Grant are available from the Fund's office szcuf@anatomy.usyd.edu.au